leadf
logo-loader
viewArcher Materials Ltd

Archer Materials builds proof-of-concept cartridge components for biosensor device

The company is progressing its graphene-based biosensor technology prototype development using low-cost, rapid 2D and 3D printing.

Archer Materials Ltd - Archer Materials builds proof-of-concept cartridge components for biosensor device
The 3D printed cartridge enclosure with two liquid wells for the placement of fluids during testing

Archer Materials Ltd (ASX:AXE) has progressed its graphene-based biosensor technology development by successfully prototyping key device hardware using additive manufacturing (3D printing).

The cartridges were printed using acrylonitrile butadiene styrene (ABS), a robust engineering plastic (e.g. used in manufacturing Lego), in less than 2 hours using ABS costing $0.50, with the cartridges weighing about 13 grams (similar to a AAA battery) and measuring a few centimetres in size (palm size).

Graphene-based biosensor devices 2D printed on a circuit board that has been incorporated into the custom-designed and 3D printed cartridge made from ABS. The cartridge is opened and the interior is shown.

Archer CEO Dr Mohammad Choucair said: “Additive manufacturing allows Archer to make prototypes of key biosensor elements in less than a few hours.

“By using 3D printing we are able to accelerate progress towards commercialising Archer’s innovative graphene-based biosensor technology.

“When the Company undertook the recent Share Purchase Plan the main purpose of the fund raising was to allow the Company to accelerate the pace of development of our key projects and technologies.

“The 3D printing of biosensor components is consistent with that strategy.”

World-class infrastructure, facilities, R&D personnel, and best-in-class 3D and 2D printers are available to Archer through the company’s collaboration with the University of Adelaide, as a founding industry partner of the ARC Research Hub for Graphene Enabled Industry Transformation (ARC Graphene Hub).

An international patent has now been published by the World Intellectual Property Organisation (WIPO) to protect and commercialise intellectual property (IP) associated with the graphene-based biosensor materials technology.

Chemistry is key

There are very few materials in existence capable of performing biosensing rapidly and accurately for human health diagnostics.

Archer’s technology development has an ongoing focus on exploiting the advanced chemistry of its new graphene materials to arrive at a minimal viable product capable of rapid multi-disease detection and portable device integration.

Quick facts: Archer Materials Ltd

Price: 0.47 AUD

ASX:AXE
Market: ASX
Market Cap: $105.67 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Archer Materials Ltd named herein, including the promotion by the Company of Archer Materials Ltd in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Archer Materials can fast-track development of its qubit chip with new...

Archer Materials Ltd's (ASX:AXE) (OTCMKTS:ARRXF) CEO Mohammad Choucair tells Proactive that new computational models have been developed which for the first time can accurately predict its CQ qubit behaviour which is necessary for successful chip operation. He adds that it's a validation of...

2 weeks, 3 days ago

2 min read